Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 6, 2011
April 29, 2020
c8804eda-e868-4190-aaf3-700e3b13cf9e
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Guidance DocumentMarch 13, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox